Valuation : Captor Therapeutics Spolka Akcyjna

Market Cap 451M 121M 104M 98.18M 89.45M 167M 11.41B 168M 1.16B 5.83B 454M 444M 19.17B P/E 2026 *
23.1x
P/E 2027 * -11.1x
Enterprise Value 379M 101M 87.47M 82.4M 75.07M 140M 9.58B 141M 976M 4.9B 381M 372M 16.09B EV / Sales 2026 *
6.68x
EV / Sales 2027 * 41.9x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 week-2.74%
Current month-1.25%
1 month-4.31%
3 months-5.96%
6 months-14.25%
Current year-1.39%
1 week 68.3
Extreme 68.3
71.9
1 month 67.2
Extreme 67.2
74
Current year 67.2
Extreme 67.2
89.2
1 year 33
Extreme 33
89.2
3 years 31.2
Extreme 31.2
132
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 31/05/2025
Director of Finance/CFO - 01/02/2025
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Chairman 54 30/06/2022
Director/Board Member 74 30/06/2022
Director/Board Member - 30/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
26/02/26 Buy 1,100 0.0198%
12/12/25 Free

Chairman

360,074 6.5128%
12/12/25 Don

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.74%+82.05%-44.53% 121M
+0.97%-0.75%+3.51%+18.46% 49.74B
-0.30%-2.88%+429.29%+496.95% 44.98B
+2.13%+0.89%+43.59%+17.61% 42.52B
+0.87%-3.73%+8.96%+73.17% 40.78B
-0.90%-1.74%+15.20%+48.44% 32.89B
+2.71%+6.82% - - 17.09B
+1.68%-4.20%+25.28%+116.83% 16.28B
+1.70%-0.05%+18.53%+28.50% 14.4B
+3.34%-1.13%+80.94%+39.19% 13.48B
Average +1.22%-1.54%+78.60%+88.29% 27.23B
Weighted average by Cap. +1.01%-1.78%+93.98%+123.17%

Financials

2026 *2027 *
Net sales 56.7M 15.18M 13.1M 12.34M 11.24M 21.02M 1.43B 21.17M 146M 733M 57.02M 55.77M 2.41B 10M 2.68M 2.31M 2.18M 1.98M 3.71M 253M 3.73M 25.77M 129M 10.06M 9.84M 425M
Net income -3M -803K -693K -653K -595K -1.11M -75.9M -1.12M -7.73M -38.8M -3.02M -2.95M -127M -41M -10.98M -9.47M -8.92M -8.13M -15.2M -1.04B -15.31M -106M -530M -41.23M -40.33M -1.74B
Net Debt -72.5M -19.42M -16.75M -15.78M -14.38M -26.87M -1.83B -27.07M -187M -938M -72.91M -71.32M -3.08B -32M -8.57M -7.39M -6.96M -6.35M -11.86M -810M -11.95M -82.45M -414M -32.18M -31.48M -1.36B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
-
Date Price Change Volume
02/09/26 PLN 71.00 0.00% 2,450
01/09/26 PLN 71.00 -1.25% 1,910
31/08/26 PLN 71.90 +1.27% 2,014
28/08/26 PLN 71.00 -0.14% 1,890
27/08/26 PLN 71.10 -2.60% 858
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
71.00PLN
Average target price
86.83PLN
Spread / Average Target
+22.30%

Quarterly revenue - Rate of surprise